ALF-STONE: Alfuzosin in Uretheric Stones

Summary

The aim of the study is to assess the effect of Alfuzosin compared with placebo, for 7 days, on the outcome of patients with uretheric stones submitted to Extracorporeal Shock Wave Lithotripsy (ESWL), namely in the percentage of patients without imagiologic evidence of any stone after 72h to 96 hours. This study will also specifically focus on the evaluation of time of stone clearance and of pain reduction (Numeric Rating Scale).

Timeline

Start

2006-08

Primary completion

—

Completion

2007-07

Outcome

Outcome not reported

Stopped (Enrollment): “Discontinued due to incomplete recruitment”

Drugs

Indications